3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Obesity
1
Neuralgia
1
Inflammation
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
Tirzepatide
5
semaglutide
2
Observation
2
Metformin
2
Exercise
2
Counseling
2
mirabegron
1
atezolizumab
1
Weights and Measures
1
Walk Test
1
Trehalase
1
Therapeutics
1
Tablets
1
TIC10 compound
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Resistance Training
1
Progestins
1
Pregabalin
1
Population Groups
1
Omeprazole
1
Nutrition Assessment
1
Negative-Pressure Wound Therapy
1
Methods
1
Metabolic Networks and Pathways
1
Liraglutide
1
Letrozole
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Ketorolac
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Obesity
×
Pregabalin
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled